The Alzheimer’s Disease and Memory Disorders Center (ADMDC) conducts clinical trials that give participants access to the latest, most comprehensive diagnostic and treatment options available.

There is currently no cure for Alzheimer's disease, but scientists are constantly working to advance research through clinical studies with the help of human volunteers. Without these volunteers, there can be no better treatments, prevention, or cure for Alzheimer's.

Both people with the disease and healthy volunteers are needed for Alzheimer's-related clinical trials. Before joining a clinical trial, an individual must qualify for the study. All clinical trials have guidelines about who can participate. These criteria are based on factors such as age, gender, the type and stage of the disease, previous treatment history, and other medical conditions.

Studies Currently Recruiting Study Patients

Studies Currently Active (Closed to Enrollment)

Clinical and Translational Research Center

The research focus of this laboratory is to characterize the contribution of CNVs to the genetic architecture of AD to develop genetic biomarkers for risk stratification.